Renaissance Technologies - HOMOLOGY MEDICINES INC ownership

HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 86 filers reported holding HOMOLOGY MEDICINES INC in Q2 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HOMOLOGY MEDICINES INC
ValueSharesWeighting
Q3 2023$211
-20.4%
180,000
-39.8%
0.00%
Q2 2023$265
-16.7%
299,100
-3.3%
0.00%
Q1 2023$318
-24.3%
309,217
-7.2%
0.00%
-100.0%
Q4 2022$420
-99.9%
333,153
-12.1%
0.00%0.0%
Q3 2022$610,000
+24.5%
379,100
+52.4%
0.00%0.0%
Q2 2022$490,000
-31.1%
248,800
+6.3%
0.00%0.0%
Q1 2022$711,000
+33.9%
234,000
+60.3%
0.00%0.0%
Q4 2021$531,000
-61.2%
145,993
+61.9%
0.00%0.0%
Q2 2020$1,370,000
+63.9%
90,200
+67.7%
0.00%0.0%
Q1 2020$836,00053,7860.00%
Other shareholders
HOMOLOGY MEDICINES INC shareholders Q2 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 4,535,919$5,307,0251.53%
Western Standard LLC 250,060$292,5700.26%
OUP Management Co., LLC 64,000$74,8800.17%
Vivo Capital, LLC 370,068$432,9800.05%
Temasek Holdings (Private) Ltd 5,650,996$6,611,6650.04%
GEORGE KAISER FAMILY FOUNDATION 39,320$46,0040.01%
American Investment Services, Inc. 36,955$43,2380.01%
RBF Capital, LLC 58,700$68,6790.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 185,100$216,5670.01%
XTX Topco Ltd 21,188$24,7900.00%
View complete list of HOMOLOGY MEDICINES INC shareholders